What is the main cause of myocardial infarction A cardiologist explains how atherosclerosis and blood clots trigger heart ...

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

Confused about the difference between a myocardial infarction and a heart attack Read ahead as an expert explains the causes symptoms and why acting fast is crucial for your heart health ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

Revascularization of all vessels with stenosis was linked to lower rates of death, another MI, and further revascularization ...

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

In an exclusive chat with Deccan Chronicle, Kshemavana’s Chief Wellness Officer warns against drug abuse, nutraceutical ...

In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and ...

For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...